• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环非编码 RNA 在垂体神经内分泌肿瘤中的作用——同一事物的两个方面。

Circulating Noncoding RNAs in Pituitary Neuroendocrine Tumors-Two Sides of the Same Coin.

机构信息

Hereditary Tumours Research Group, Hungarian Academy of Sciences-Semmelweis University, H-1089 Budapest, Hungary.

Department of Laboratory Medicine, Semmelweis University, H-1089 Budapest, Hungary.

出版信息

Int J Mol Sci. 2022 May 4;23(9):5122. doi: 10.3390/ijms23095122.

DOI:10.3390/ijms23095122
PMID:35563510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9101693/
Abstract

Pituitary neuroendocrine tumors (PitNET) are common intracranial neoplasms. While in case of hormone secreting tumors pituitary hormone measurements can be used for monitoring the disease, in non-functional tumors there is a need to discover non-invasive biomarkers. Non-coding RNAs (ncRNAs) are popular biomarker candidates due to their stability and tissue specificity. Among ncRNAs, miRNAs, lncRNAs and circRNAs have been investigated the most in pituitary tumor tissues and in circulation. However, it is still not known whether ncRNAs are originated from the pituitary, or whether they are casually involved in the pathophysiology. Additionally, there is strong diversity among different studies reporting ncRNAs in PitNET. Therefore, to provide an overview of the discrepancies between published studies and to uncover the reasons why despite encouraging experimental data application of ncRNAs in clinical routine has not yet taken hold, in this review available data are summarized on circulating ncRNAs in PitNET. The data on circulating miRNAs, lncRNAs and circRNAs are organized according to different PitNET subtypes. Biological (physiological and pathophysiological) factors behind intra- and interindividual variability and technical aspects of detecting these markers, including preanalytical and analytical parameters, sample acquisition (venipuncture) and type, storage, nucleic acid extraction, quantification and normalization, which reveal the two sides of the same coin are discussed.

摘要

垂体神经内分泌肿瘤(PitNET)是常见的颅内肿瘤。在激素分泌性肿瘤的情况下,可以使用垂体激素测量来监测疾病,但在无功能性肿瘤中,需要发现非侵入性的生物标志物。由于其稳定性和组织特异性,非编码 RNA(ncRNA)是很受欢迎的生物标志物候选物。在垂体肿瘤组织和循环中,miRNA、lncRNA 和 circRNA 研究最多。然而,目前尚不清楚 ncRNA 是来自垂体,还是偶然参与病理生理学。此外,不同研究报告 PitNET 中的 ncRNA 存在很大差异。因此,为了概述已发表研究之间的差异,并揭示尽管实验数据令人鼓舞,但 ncRNA 在临床常规中的应用尚未普及的原因,在本综述中,总结了关于 PitNET 中循环 ncRNA 的现有数据。根据不同的 PitNET 亚型,对循环 miRNA、lncRNA 和 circRNA 的数据进行了组织。讨论了个体内和个体间变异性的生物学(生理和病理生理)因素以及检测这些标志物的技术方面,包括分析前和分析参数、样本采集(静脉穿刺)和类型、储存、核酸提取、定量和归一化,揭示了同一枚硬币的两面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/f3315f451b7d/ijms-23-05122-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/344e754a7439/ijms-23-05122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/2d2f44e0b303/ijms-23-05122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/0f5e7e5a8cf9/ijms-23-05122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/5330fb297e13/ijms-23-05122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/f3315f451b7d/ijms-23-05122-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/344e754a7439/ijms-23-05122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/2d2f44e0b303/ijms-23-05122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/0f5e7e5a8cf9/ijms-23-05122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/5330fb297e13/ijms-23-05122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3553/9101693/f3315f451b7d/ijms-23-05122-g005.jpg

相似文献

1
Circulating Noncoding RNAs in Pituitary Neuroendocrine Tumors-Two Sides of the Same Coin.循环非编码 RNA 在垂体神经内分泌肿瘤中的作用——同一事物的两个方面。
Int J Mol Sci. 2022 May 4;23(9):5122. doi: 10.3390/ijms23095122.
2
Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma.微小 RNA、长链非编码 RNA、环状 RNA 的新兴作用及其在垂体腺瘤中的相互作用。
Cells. 2022 Sep 19;11(18):2920. doi: 10.3390/cells11182920.
3
Circulating non-coding RNA biomarkers of endocrine tumours.循环非编码 RNA 标志物在内分泌肿瘤中的应用。
Nat Rev Endocrinol. 2024 Oct;20(10):600-614. doi: 10.1038/s41574-024-01005-8. Epub 2024 Jun 17.
4
Non-coding RNAs and exosomal non-coding RNAs in pituitary adenoma.垂体腺瘤中的非编码RNA和外泌体非编码RNA
Pathol Res Pract. 2023 Aug;248:154649. doi: 10.1016/j.prp.2023.154649. Epub 2023 Jun 28.
5
NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease.非编码RNA:阿尔茨海默病中一种协同抗凋亡的治疗工具。
CNS Neurosci Ther. 2024 Apr;30(4):e14476. doi: 10.1111/cns.14476. Epub 2023 Sep 22.
6
The role of noncoding RNAs in pituitary adenoma.非编码 RNA 在垂体腺瘤中的作用。
Epigenomics. 2021 Sep;13(17):1421-1437. doi: 10.2217/epi-2021-0165. Epub 2021 Sep 24.
7
Non-coding RNAs: key players in cardiac disease.非编码 RNA:心脏疾病的关键参与者。
J Physiol. 2020 Jul;598(14):2995-3003. doi: 10.1113/JP278131. Epub 2019 Jul 26.
8
The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.循环非编码 RNA 生物标志物研究图谱:心血管疾病的经验与展望。
Acta Pharmacol Sin. 2018 Jul;39(7):1085-1099. doi: 10.1038/aps.2018.35. Epub 2018 Jun 7.
9
Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.非编码 RNA 作为液体活检中的生物标志物,特别关注泌尿系统恶性肿瘤中外泌体。
Expert Rev Mol Diagn. 2020 Feb;20(2):151-167. doi: 10.1080/14737159.2019.1665998. Epub 2019 Sep 18.
10
Roles of noncoding RNAs in septic acute kidney injury.非编码 RNA 在脓毒症急性肾损伤中的作用。
Biomed Pharmacother. 2023 Sep;165:115269. doi: 10.1016/j.biopha.2023.115269. Epub 2023 Aug 2.

引用本文的文献

1
Liquid Biopsy in Pituitary Neuroendocrine Tumors-Potential Biomarkers for Diagnosis, Prognosis, and Therapy.垂体神经内分泌肿瘤中的液体活检——用于诊断、预后和治疗的潜在生物标志物
Int J Mol Sci. 2025 Apr 25;26(9):4058. doi: 10.3390/ijms26094058.
2
Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism.循环微小RNA与机器学习用于原发性醛固酮增多症的定位诊断
Hypertension. 2024 Dec;81(12):2479-2488. doi: 10.1161/HYPERTENSIONAHA.124.23418. Epub 2024 Oct 17.
3
Circulating non-coding RNA biomarkers of endocrine tumours.

本文引用的文献

1
An Exploration of Non-Coding RNAs in Extracellular Vesicles Delivered by Swine Anterior Pituitary.猪垂体前叶分泌的细胞外囊泡中非编码RNA的探索
Front Genet. 2021 Nov 29;12:772753. doi: 10.3389/fgene.2021.772753. eCollection 2021.
2
The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma.非编码RNA在垂体瘤和脑膜瘤中的新兴作用
Cancers (Basel). 2021 Nov 28;13(23):5987. doi: 10.3390/cancers13235987.
3
Circulating MicroRNAs as Non-invasive Biomarkers for Canine Cushing's Syndrome.循环微小RNA作为犬库欣氏综合征的非侵入性生物标志物
循环非编码 RNA 标志物在内分泌肿瘤中的应用。
Nat Rev Endocrinol. 2024 Oct;20(10):600-614. doi: 10.1038/s41574-024-01005-8. Epub 2024 Jun 17.
4
Editorial: Predictive and prognostic value of liquid biopsy biomarkers in metastatic cancers: from basic science, across high throughput profiling up to clinical practice.社论:液体活检生物标志物在转移性癌症中的预测和预后价值:从基础科学,到高通量分析,直至临床实践
Front Oncol. 2024 Mar 18;14:1375711. doi: 10.3389/fonc.2024.1375711. eCollection 2024.
5
[Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies].[基因确诊的1型多发性内分泌腺瘤综合征患者及其表型模拟者的血浆微小RNA表达]
Probl Endokrinol (Mosk). 2024 Jan 24;69(6):70-85. doi: 10.14341/probl13357.
6
Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy.肿瘤微环境在垂体神经内分泌肿瘤中的作用:分类、诊断和治疗的新方法
Cancers (Basel). 2023 Nov 6;15(21):5301. doi: 10.3390/cancers15215301.
7
Expression of cAMP and oxidative phosphorylation-related lncRNAs in non-functioning pituitary adenomas.无功能垂体腺瘤中 cAMP 和氧化磷酸化相关 lncRNAs 的表达。
J Cell Mol Med. 2023 Dec;27(24):4195-4201. doi: 10.1111/jcmm.18011. Epub 2023 Nov 6.
8
Pituitary Tumorigenesis-Implications for Management.垂体肿瘤发生-对治疗的影响。
Medicina (Kaunas). 2023 Apr 21;59(4):812. doi: 10.3390/medicina59040812.
9
The Emerging Role of Epigenetics in Metabolism and Endocrinology.表观遗传学在代谢与内分泌学中的新兴作用
Biology (Basel). 2023 Feb 6;12(2):256. doi: 10.3390/biology12020256.
10
Special Issue "miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics 2.0".专刊:个性化医学时代的 miRNA:从生物标志物到治疗 2.0
Int J Mol Sci. 2023 Jan 19;24(3):1951. doi: 10.3390/ijms24031951.
Front Vet Sci. 2021 Nov 17;8:760487. doi: 10.3389/fvets.2021.760487. eCollection 2021.
4
Plasma microRNA Interindividual Variability in Healthy Individuals, Pregnant Women, and an Individual with a Stably Altered Neuroendocrine Phenotype.健康个体、孕妇和具有稳定改变的神经内分泌表型个体的血浆 microRNA 个体间变异性。
Clin Chem. 2021 Nov 26;67(12):1676-1688. doi: 10.1093/clinchem/hvab193.
5
Circulating Plasma MicroRNA in Patients With Active Acromegaly.活性肢端肥大症患者循环血浆中的 microRNA。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):500-511. doi: 10.1210/clinem/dgab695.
6
Differential non-coding RNAs expression profiles of invasive and non-invasive pituitary adenomas.侵袭性和非侵袭性垂体腺瘤的差异非编码RNA表达谱
Noncoding RNA Res. 2021 Jun 30;6(3):115-122. doi: 10.1016/j.ncrna.2021.06.004. eCollection 2021 Sep.
7
Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors.14q32编码的微小RNA在内分泌肿瘤中的重要作用。
Genes (Basel). 2021 May 8;12(5):698. doi: 10.3390/genes12050698.
8
Circulating miR-29c-3p is downregulated in patients with acromegaly.循环 miR-29c-3p 在肢端肥大症患者中下调。
Turk J Med Sci. 2021 Aug 30;51(4):2081-2086. doi: 10.3906/sag-2010-245.
9
Circulating microRNA Expression in Cushing's Syndrome.库欣综合征中的循环 microRNA 表达。
Front Endocrinol (Lausanne). 2021 Feb 22;12:620012. doi: 10.3389/fendo.2021.620012. eCollection 2021.
10
Exosomal circRNAs as novel cancer biomarkers: Challenges and opportunities.外泌体环状 RNA 作为新型癌症生物标志物:挑战与机遇。
Int J Biol Sci. 2021 Jan 14;17(2):562-573. doi: 10.7150/ijbs.48782. eCollection 2021.